Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 14, 1999, Pages 1937-1940

  Matsumoto, Yoko ^a   Kato, Toshihiro ^a   Iseki, Shinji ^a   Suzuki, Hitoshi ^a   Nakano, Koji ^a   Iwahara, Masayoshi ^b   Ueoka, Ryuichi ^a  

^a Graduate Course of Appl Chemistry   (Japan)

^b SOJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMYRISTOYL 3 TRIMETHYLAMMONIUM PROPANE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; DODECYL ETHER; ETHER DERIVATIVE; LIPOSOME; POLYOXYETHYLENE; PROPANE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYBRIDIZATION; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; STOMACH TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LIPOSOMES; LUNG NEOPLASMS; MICE; MICELLES; MYRISTATES; PHOSPHATIDYLGLYCEROLS; POLYETHYLENE GLYCOLS; QUATERNARY AMMONIUM COMPOUNDS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033584212     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00303-0     Document Type: Article

References (15)

1. Lasic.D.D. et al ., "Liposomes : From Physics to Application", Elsevier, the Netherlands, 1993, 261-286.
2. Ueoka, R.; Matsumoto, Y.; Moss, R.A.; Swarup, S.; Sugii, A.; Harada, K.; Kikuchi, J.; Murakami, Y. J. Am. Chem. Soc., 1988, 110, 1588-1595.
3. Ueoka, R.; Matsumoto, Y.; Oyama, H.; Takekuma, H.; Iio, M. Chem. Pharm. Bull., 1988, 36, 4640-4643.
4. Matsumoto, Y.; Yamada, E.; Hirano, J.; Oshige, M.; Iio, M.; Iwahara, M.; Ueoka, R. Biol. Pharm. Bull., 1993, 16, 213-215.
5. Matsumoto, Y.; Imamura, C.; Ito, T.; Taniguchi,C.; Ueoka, R. Biol. Pharm. Bull., 1995, 18, 1456-1458.
6. Imamura, C.; Kemura, Y.; Matsumoto, Y.; Ueoka, R. Biol. Pharm. Bull., 1997, 20, 1119-1120.
7. Matsumoto, Y.; Kato, T.; Kemura, Y.; Tsuchiya, M.; Yamamoto,M.; Ueoka, R.; Chem. Lett., 1999, 53-54.
8. Kitamura, I.; Kochi, M.; Matsumoto, Y.; Ueoka, R.; Kuratsu, J.; Ushio, Y. Cancer Res., 1996, 56, 3986-3992.
9. Imamura, C.; Kanno, A.; Mitsuoka, C.; Kitajima, S.; Inoue, H.; Iwahara, M.; Matsumoto, Y; Ueoka, R. Yakugaku Zasshi, 1996, 116, 942-947.
10. Kanno, A.; Kodama, R.; Terada, Y.; Matsumoto, Y.; Ueoka, R. Drug Delivery System, 1998, 13, 101-106.
11. The dynamic light scattering measurements were performed with a Brookheven BI-90 particle sizer as described in ref 2.
12. Ishiyama, M.; Shiga, M.; Sasamoto, K.; Mizoguchi, M.; He, P. G. Chem. Pharm. Bull., 1993, 41, 1118-1123.
13. Ueoka, R.; Matsumoto, Y.; Kanno, A. unpublished data.
14. Epand, R. M.; Hui, S. W. FEBS Lett., 1986, 209, 257-301.
15. Shimada, K.; Miyagishima, A.; Sadzuka, Y.; Nozawa, Y.; Mochizuki, Y.; Ohshima, H.; Hirota, S. J. Drug Target. 1995, 3, 283-290.